Toth Financial Advisory’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.41M Sell
56,404
-22,666
-29% -$1.83M 0.43% 77
2026
Q1
$6.85M Buy
79,070
+4,800
+6% +$460K 0.75% 50
2025
Q4
$7.13M Buy
74,270
+5,863
+9% +$570K 0.77% 48
2025
Q3
$6.52M Buy
68,407
+2,014
+3% +$185K 0.7% 54
2025
Q2
$5.79M Buy
66,393
+3,545
+6% +$301K 0.68% 55
2025
Q1
$5.65M Buy
62,848
+2,970
+5% +$266K 0.68% 55
2024
Q4
$4.78M Buy
59,878
+5,015
+9% +$434K 0.56% 64
2024
Q3
$4.94M Buy
54,863
+686
+1% +$57.7K 0.58% 63
2024
Q2
$4.26M Buy
54,177
+1,378
+3% +$113K 0.54% 69
2024
Q1
$4.6M Buy
52,799
+1,877
+4% +$160K 0.58% 65
2023
Q4
$4.19M Sell
50,922
-6,802
-12% -$518K 0.57% 63
2023
Q3
$4.52M Sell
57,724
-3,111
-5% -$260K 0.69% 52
2023
Q2
$5.36M Buy
60,835
+2,315
+4% +$199K 0.78% 47
2023
Q1
$4.72M Sell
58,520
-1,954
-3% -$159K 0.74% 53
2022
Q4
$4.7M Sell
60,474
-9,215
-13% -$747K 0.76% 53
2022
Q3
$5.63M Buy
69,689
+4,459
+7% +$401K 1.02% 36
2022
Q2
$5.85M Sell
65,230
-1,707
-3% -$173K 1.02% 39
2022
Q1
$7.43M Buy
66,937
+1,102
+2% +$116K 1.11% 28
2021
Q4
$6.81M Sell
65,835
-1,045
-2% -$121K 0.93% 39
2021
Q3
$8.38M Buy
66,880
+647
+1% +$83.7K 1.27% 20
2021
Q2
$8.22M Buy
66,233
+505
+0.8% +$63.4K 1.26% 23
2021
Q1
$7.76M Buy
65,728
+2,017
+3% +$236K 1.24% 24
2020
Q4
$7.46M Buy
63,711
+1,241
+2% +$137K 1.28% 23
2020
Q3
$6.49M Sell
62,470
-314
-0.5% -$31.5K 1.25% 25
2020
Q2
$5.76M Buy
62,784
+206
+0.3% +$19.8K 1.25% 28
2020
Q1
$5.64M Buy
62,578
+1,005
+2% +$107K 1.63% 17
2019
Q4
$6.99M Buy
61,573
+3,416
+6% +$375K 1.42% 20
2019
Q3
$6.32M Buy
58,157
+602
+1% +$62.8K 1.38% 26
2019
Q2
$5.61M Buy
57,555
+3,468
+6% +$317K 1.25% 30
2019
Q1
$4.93M Buy
54,087
+1,719
+3% +$154K 1.15% 32
2018
Q4
$4.76M Buy
52,368
+974
+2% +$91K 1.3% 33
2018
Q3
$5.06M Buy
51,394
+404
+0.8% +$37.4K 1.12% 36
2018
Q2
$4.37M Buy
50,990
+2,170
+4% +$181K 1.02% 38
2018
Q1
$3.92M Sell
48,820
-387
-0.8% -$31.9K 0.95% 40
2017
Q4
$3.97M Sell
49,207
-1,260
-2% -$101K 0.94% 42
2017
Q3
$3.92M Buy
50,467
+1,403
+3% +$116K 0.99% 44
2017
Q2
$4.35M Buy
49,064
+4,403
+10% +$371K 1.14% 38
2017
Q1
$3.6M Sell
44,661
-1,090
-2% -$85.1K 0.96% 45
2016
Q4
$3.26M Sell
45,751
-4,599
-9% -$361K 0.94% 48
2016
Q3
$4.35M Sell
50,350
-705
-1% -$61.4K 1.28% 30
2016
Q2
$4.43M Buy
51,055
+911
+2% +$73.7K 1.35% 27
2016
Q1
$3.76M Sell
50,144
-3,156
-6% -$238K 1.23% 35
2015
Q4
$4.1M Sell
53,300
-7,824
-13% -$589K 1.36% 32
2015
Q3
$4.09M Sell
61,124
-17,137
-22% -$1.26M 1.5% 28
2015
Q2
$5.8M Sell
78,261
-5,556
-7% -$424K 1.94% 13
2015
Q1
$6.54M Sell
83,817
-5,213
-6% -$395K 2.19% 10
2014
Q4
$6.43M Sell
89,030
-776
-0.9% -$53.9K 2.23% 8
2014
Q3
$5.56M Sell
89,806
-1,906
-2% -$121K 2.1% 11
2014
Q2
$5.85M Sell
91,712
-322
-0.3% -$19.6K 2.22% 6
2014
Q1
$5.66M Sell
92,034
-1,132
-1% -$65.9K 2.29% 6
2013
Q4
$5.35M Sell
93,166
-2,993
-3% -$170K 2.27% 10
2013
Q3
$5.12M Buy
96,159
+4,828
+5% +$260K 2.4% 9
2013
Q2
$4.7M Buy
+91,331
New +$4.51M 2.31% 11

Other funds holding MDT

Toth Financial Advisory's MDT Position: Q2 2026 in Review

Toth Financial Advisory reduced its Medtronic (MDT) stake by 29% in Q2 2026, selling an estimated $1.83M and leaving 56,404 shares worth $4.41M. The position accounts for 0.43% of the portfolio, ranked #77.

Toth Financial Advisory first reported a position in MDT in Q2 2013 and has held it in 53 quarters since. The position peaked at $8.38M in Q3 2021. 2,125 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Toth Financial Advisory held 56,404 shares of Medtronic worth $4.41M as of Q2 2026.
  • Toth Financial Advisory sold 22,666 Medtronic shares in Q2 2026, an estimated $1.83M.
  • Medtronic made up 0.43% of Toth Financial Advisory's portfolio in Q2 2026, its #77 holding.
  • Toth Financial Advisory first reported a position in Medtronic in Q2 2013 and has held it in 53 quarters since.
  • Toth Financial Advisory's Medtronic position peaked at $8.38M in Q3 2021.
  • 2,125 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Toth Financial Advisory's 13F filing for Q2 2026, filed 14 Jul 2026.